Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Weight Loss Medication Alternatives To GLP-1 Agonists (Ozempic, Wegovy, Zepbound) | GoodRx How To Lose Your Appetite
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-08-19
GLP-1 agonists like semaglutide are getting a lot of attention right now, but they’re not the only medications for weight loss. These non-injection, oral weight-loss medications include phentermine, metformin, Contrave, and Qsymia. Learn about other weight-loss medications that may help if GLP-1 agonists are not a good fit for you, according to Stacia Woodcock, PharmD, Pharmacy Editor at GoodRx.
Learn more:
Go to for the answers you need from doctors, pharmacists, and journalists you can trust.
Follow Us On Social:
TikTok -
Instagram -
Facebook -
Twitter -
#weightlossmedication #weightlosspills #weightloss
Weight Loss Medication Alternatives To GLP-1 Agonists (Ozempic, Wegovy, Zepbound) | GoodRx For Country: United States. City: Baltimore, Buffalo, Madison, Shreveport, Spokane
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication